Human Genome Sciences Adopts Poison Pill to Thwart Glaxo Takeover – New York Times
The biotechnology company Human Genome Sciences on Thursday adopted a shareholder rights plan, or poison pill, as it sought to fend off a $2.59 billion takeover offer from the drug maker GlaxoSmithKline. The news comes a week after Glaxo …